Arterial Hypertension and Diabetes Mellitus in COVID-19 Patients: What Is Known by Gender Differences?

Abstract

Background. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has infected >160 million people around the world. Hypertension (HT), chronic heart disease (CHD), and diabetes mellitus (DM) increase susceptibility to SARS-CoV-2 infection. Aims. We designed this retrospective study to assess the gender differences in hypertensive diabetic SARS-CoV-2 patients. We reported data, by gender differences, on the inflammatory status, on the hospital stays, intensive care unit (ICU) admission, Rx and CT report, and therapy. Methods. We enrolled 1014 patients with confirmed COVID-19 admitted into different Hospitals of Campania from 26 March to 30 June, 2020. All patients were allocated into two groups: diabetic-hypertensive group (DM-HT group) that includes 556 patients affected by diabetes mellitus and arterial hypertension and the non-diabetic- non-hypertensive group (non-DM, non-HT group) comprising 458 patients. The clinical outcomes (i.e., discharges, mortality, length of stay, therapy, and admission to intensive care) were monitored up to June 30, 2020. Results. We described, in the DM-HT group, higher proportion of cardiopathy ischemic (CHD) (47.5% vs. 14.8%, respectively; p < 0.0001) and lung diseases in females compared to male subjects (34.8% vs. 18.5%, respectively; p < 0.0001). In male subjects, we observed higher proportion of kidney diseases (CKD) (11% vs. 0.01%, respectively; p < 0.0001), a higher hospital stay compared to female subjects (22 days vs. 17 days, respectively, p < 0.0001), a higher admission in ICU (66.9% vs. 12.8%, respectively, p < 0.0001), and higher death rate (17.3% vs. 10.7%, respectively, p < 0.0001). Conclusion. These data confirm that male subjects, compared to female subjects, have a higher hospital stay, a higher admission to ICU, and higher death rate.

Risk of Hypertension and Type 2 Diabetes in Relation to Changes in Alcohol Consumption: A Nationwide Cohort Study

“…Given that hypertension and diabetes mellitus are leading causes of premature death and are significant risk factors for kidney and cardiovascular diseases [4][5][6], prevention of these conditions is an important worldwide public health priority. Furthermore, globally, the number of confirmed cases of COVID-19 is 476.4 million, including 6.1 million deaths according to the World Health Organization (WHO), the spread of COVID-19 is predicted to increase worldwide [7], and diabetes and hypertension seem to negatively affect the clinical course and disease outcome in patients with COVID-19 [8].…”

Assisting individuals with diabetes in the COVID-19 pandemic period: Examining the role of religious factors and faith communities

“…If clinicians hope to achieve effective outcomes in the management of diabetes, they must consider factors such as patients' comorbidities, gender, age, and educational level that may affect perceptions of diabetes management on the part of patients and their relatives. As reported by Ciarambino et al [ 114 ] in a retrospective study, there were differences between male and female patients with hypertension and diabetes who contracted SARS-CoV-2. There was a longer hospital stay, an increased number of admissions to the intensive care unit, and an increased death rate for male patients compared to female patients, according to their findings.…”

An integrated approach-demographic, clinical, laboratory and radiological features in predicting mortality of sars-cov-2 patients in critical care medicine

“…Thus, these factors require a more vigilant monitoring. Diabetes and Hypertension were shown to be the most common co morbidities in COVID-19 patients [16,17] . Majority of the patients enrolled in this study were diabetic and hypertensive.…”